About CRI Centro Regiomontano de Investigacion S.C.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at CRI Centro Regiomontano de Investigacion S.C.
During the past decade, CRI Centro Regiomontano de Investigacion S.C. conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 13 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 9 clinical trials were completed. i.e. 81.8%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "CRI Centro Regiomontano de Investigacion S.C." #1 sponsor was "Eli Lilly and Company" with 7 trials, followed by "H. Lundbeck A/S" with 4 trials
sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored and "Celgene"
with 4 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "CRI Centro Regiomontano de Investigacion S.C."
#1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "NSABP Foundation Inc" with 1 trials as a collaborator, "Parexel" with 1 trials as a collaborator and "Takeda" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at CRI Centro Regiomontano de Investigacion S.C.
According to Clinical.Site data, the most researched conditions in "CRI Centro Regiomontano de Investigacion S.C." are
"Colitis, Ulcerative" (4 trials), "Crohn Disease" (4 trials), "Depressive Disorder, Major" (3 trials), "Atopic Dermatitis" (2 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "CRI Centro Regiomontano de Investigacion S.C." in a lesser frequency.
Clinical Trials Intervention Types at CRI Centro Regiomontano de Investigacion S.C.
Most popular intervention types in "CRI Centro Regiomontano de Investigacion S.C." are "Drug" (30 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (20 trials), "Baricitinib" (3 trials), "Ozanimod" (3 trials), "Vortioxetine" (3 trials) and "Abemaciclib" (2 trials). Other intervention names were less common.
Clinical Trials Genders at CRI Centro Regiomontano de Investigacion S.C.
The vast majority of trials in "CRI Centro Regiomontano de Investigacion S.C." are
30 trials for "All" genders.
Clinical Trials Status at CRI Centro Regiomontano de Investigacion S.C.
Currently, there are NaN active trials in "CRI Centro Regiomontano de Investigacion S.C.".
1 are not yet recruiting,
10 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in CRI Centro Regiomontano de Investigacion S.C.,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in CRI Centro Regiomontano de Investigacion S.C., 0 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 23 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".